Verastem Oncology
VSTM
$10.90
Share price
5.21%
Change (1 day)
2,377.27%
Change (1 year)
Categories
Verastem Oncology (VSTM) - Total assets
Total assets on the balance sheet as of December 2023 : $0.14 B
According to Verastem Oncology 's latest financial reports the company's total assets are $0.14 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Verastem Oncology - Total assets on balance sheet (from 2011 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $95.05 M | -12.53% |
| 2021-12-31 | $0.10 B | -29.6% |
| 2020-12-31 | $0.15 B | 6.41% |
| 2019-12-31 | $0.14 B | -47.68% |
| 2018-12-31 | $0.27 B | 208.76% |
| 2017-12-31 | $89.79 M | 7.37% |
| 2016-12-31 | $83.62 M | -26.05% |
| 2015-12-31 | $0.11 B | 14.64% |
| 2014-12-31 | $98.64 M | -21.25% |
| 2013-12-31 | $0.12 B | 34.8% |
| 2012-12-31 | $92.92 M | 57.4% |
| 2011-12-31 | $59.03 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 151,185.08% | 🇺🇸 USA |
 LabCorp LH | $16.72 B | 11,071.07% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 50,069.92% | 🇬🇧 UK |
 Curis CRIS | $77.28 M | -48.38% | 🇺🇸 USA |